Related Experiment Video
Updated: Mar 6, 2026

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
Published on: August 16, 2019
Silent Myocardial Infarction Revisited: Immuno-metabolic Mechanisms, Multimodal Biomarkers, and Translational
Yashvi Pethani1, Neha Pethani2, Dilip Pethani3
1Department of Internal Medicine, Oak Hill Hospital, Brookville, FL, USA.
None:
Silent Myocardial Infarction (SMI) is a clinically underrecognized phenotype along the myocardial infarction continuum that progresses without anginal symptoms. Its prevalence in diabetes, chronic kidney disease, and the elderly reflects contributions from neuropathy, autonomic dysfunction, and neurogenic silencing. Emerging evidence indicates that SMI reflects a biologically biased phenotype within the myocardial infarction continuum shaped by immune-metabolic and neurogenic modulation rather than representing a distinct entity. Biomarkers such as sCD36, galectin-3, sST2, and GDF-15 capture fibrotic and inflammatory remodeling, while NETosis-linked markers (CitH3, MPO-DNA) highlight thrombo-inflammation. Lipidomic stressors, including ceramides and β-hydroxybutyrate, further define ischemic burden. Spatial omics and single-cell analyses identify enrichment of immune-regulatory macrophage programs associated with restrained inflammation without establishing the causality for symptom absence. A tiered approach-biomarker screening followed by imaging-supports risk stratification. This review integrates mechanistic and translational insights, proposing a pragmatic framework for early diagnosis and biologically aligned treatment of SMI.
Related Concept Videos
Myocarditis I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease II: Pathophysiology

